Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes
<p>Abstract</p> <p>Background</p> <p>An effective vaccine and new therapeutic methods for hepatitis C virus (HCV) are needed, and a potent HCV vaccine must induce robust and sustained cellular-mediated immunity (CMI). Research has indicated that adenoviral and vaccinia...
Main Authors: | Guan Jie, Wen Bo, Deng Yao, Zhang Ke, Chen Hong, Wu Xiaobing, Ruan Li, Tan Wenjie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/8/1/506 |
Similar Items
-
Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens
by: Babita Agrawal, et al.
Published: (2019-05-01) -
Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.
by: Shakti Singh, et al.
Published: (2016-01-01) -
Induction of broadly neutralising HCV antibodies in mice by integration-deficient lentiviral vector-based pseudotyped particles.
by: Yao Deng, et al.
Published: (2013-01-01) -
Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension
by: Babita Agrawal, et al.
Published: (2017-07-01) -
Immunopotentiating and Delivery Systems for HCV Vaccines
by: Alexander K. Andrianov, et al.
Published: (2021-05-01)